Skip to main content

Genzyme founder Henri Termeer co-founds biotech aimed at Parkinson's

A new biotech co-founded by Genzyme founder Henri Termeer is looking to exploit known genetic links between Gaucher and Parkinson’s disease to come up with new drugs to treat both...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.